We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
YM Bio. Com Shs | LSE:YMBA | London | Ordinary Share | CA9842381050 | COM SHS NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 75.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:5654D YM BioSciences Inc. 25 May 2006 YM BioSciences Inc. (the "Company") The Company announces that 5,675,287 common shares have been issued as partial vendor consideration in conjunction with the acquistion of Eximias Pharmaceutical Corporation. Application has been made for these shares to be admitted to AIM. This information is provided by RNS The company news service from the London Stock Exchange END IOEIIFIDEEIEFIR
1 Year YM Bio. Com Shs Chart |
1 Month YM Bio. Com Shs Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions